Showing results (171-180 of 717) with videos related to
Sort By:
Pageof 72
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapyW Garrett Nichols, Katherine A Guthrie, Lawrence Corey, et al.Influenza and Other Respiratory Viruses|June 15, 2011
Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized childrenEmily T Martin, Jane Kuypers, Anna Wald, et al.Sexually Transmitted Diseases|August 8, 2008
Internet and email use among STD clinic patientsKaren E Mark, Anna Wald, Linda Drolette, et al.Sexually Transmitted Diseases|June 1, 2007
Famciclovir reduces viral mucosal shedding in HSV-seropositive personsPeter Leone, Terri Warren, Kamal Hamed, et al.The Journal of Infectious Diseases|October 13, 2004
Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemicsSally Blower, Anna Wald, Hayley Gershengorn, et al.American Journal of Infection Control|November 6, 2007
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistanceRobert C Moellering, John R Graybill, John E McGowan, et al.Vaccine|October 26, 2005
Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvertH Nina Kim, Stephen R Tabet, Lawrence Corey, et al.The Journal of Infectious Diseases|January 25, 2002
High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infectionW Garrett Nichols, Lawrence Corey, Ted Gooley, et al.Journal of Virology|December 7, 2007
Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblastsTao Peng, Jia Zhu, Yon Hwangbo, et al.Journal of Virology|October 18, 2005
How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?W David Wick, Otto O Yang, Lawrence Corey, et al.Pageof 72